Photopheresis or extracorporeal photochemotherapy (ECP) is a novel immunomodulatory
therapy which involves separation of the patient's leucocyte‐rich plasma, followed by ex vivo …

Extracorporeal photopheresis (ECP) procedure is based on mononuclear cells (MNC)
apheresis and their extracorporeal UVA exposure. It has been applied mainly in hematology …

The GvHD is a major cause of morbidity and mortality after allogeneic hematopoietic stem
cell transplantation (HSCT). Extracorporeal photopheresis (ECP) represents an alternative …

Allogeneic haematopoietic stem cell transplantation [HSCT] is the established therapeutic
option for many patients with malignant and non-malignant diseases, but despite …

Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality following
allogeneic stem cell transplantation (ASCT). Extracorporeal photopheresis (ECP) has been …

Background Graft vs host disease (GVHD) is the most severe complication of allogeneic
hematopoietic cell transplantation. Conventional immunosuppressive therapy increases …

Extracorporeal photopheresis (ECP) is an autologous immunomodulatory cell therapy that
consists of the ex vivo collection of mononuclear cells (MNCs), which are irradiated with …

Extracorporeal photochemotherapy (ECP) has been shown to be an effective therapy for
patients with acute and chronic graft-versus-host disease (GVHD) following allogeneic bone …

Photopheresis (extracorporeal photochemotherapy, ECP) is a new type of
photochemotherapy used for the treatment of oncological and autoimmune diseases …

Extracorporeal photopheresis (ECP) has been demonstrated to be clinically effective for the
treatment of steroid‐refractory graft‐versus‐host‐disease (GvHD). Recently, a murine model …